We have entered into a sales agreement (the "Sales Agreement") with Rodman & Renshaw LLC ("Rodman" or the "Sales Agent"), dated August 26, 2026, relating to the sale of our ordinary shares, par value of US$0.01 per share ("Ordinary Shares"), offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell our Ordinary Shares, having an aggregate offering price of up to $75,000,000 from time to time through or to Rodman as sales agent or principal.

 

Sales of our Ordinary Shares, if any, under this prospectus supplement may be made in sales deemed to be "at the market offerings" as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the "Securities Act"). Rodman is not required to sell any specific number or dollar amount of securities, but will act as a sales agent using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between Rodman and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.

 

Rodman will be entitled to compensation at a commission rate of up to 3.0% of the gross sales price per share sold pursuant to the terms of the Sales Agreement. See "Plan of Distribution" beginning on page S-12 for additional information regarding the compensation to be paid to Rodman in connection with the sale of the Ordinary Shares on our behalf, Rodman will be deemed to be an "underwriter" within the meaning of the Securities Act, and the compensation of Rodman will be deemed to be underwriting commissions or discounts. We also have agreed to provide indemnification and contribution to Rodman with respect to certain liabilities, including liabilities under the Securities Act or the Exchange Act of 1934, as amended (the "Exchange Act").

 

Our Ordinary Shares are listed on the Nasdaq Capital Market under the symbol "WETO". As of July 6, 2026, the aggregate market value of our Ordinary Shares held by non-affiliates (our public float) was approximately $76,235,664, based on 82,080,000 Ordinary Shares outstanding, of which 65,720,400 Ordinary Shares were held by non-affiliates, at a price of $1.16 per share (the closing sales price of our Ordinary Shares on June 11, 2026, which was the highest closing price on The Nasdaq Capital Market within 60 days prior to July 6, 2026). Because our public float exceeded $75 million as of that date, we are not subject to the limitations under General Instruction I.B.5 of Form F-3 until the filing date of our Annual Report on Form 20-F for the fiscal year ending June 30, 2026. We have sold approximately $14,246 of securities pursuant to General Instruction I.B.5 of Form F-3 during the prior 12-calendar month period that ends on and includes the date of this prospectus supplement (excluding this offering). The number of shares and per share price in this paragraph are stated without giving effect to the 1-for-100 reverse stock split which became effective on August 3, 2026.